The impact of nutritional therapy in malnourished patient with tongue squamous cell carcinoma undergoing chemoradiation

A case report

  • Debtia Rahmah Department of Nutrition, Faculty of Medicine, University of Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
  • Diana Sunardi Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • Nurul Ratna Mutu Manikam Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Keywords: tongue carcinoma, malnutrition, nutritional therapy, cachexia, chemoradiotherapy

Abstract

Background: Malnutrition affects 30%-50% of patients with head and neck carcinoma. It is associated with reduced survival, increased risk of complications, treatment interruption, and higher treatment-related toxicity.1,2 Objective: This case aim to discuss about nutritional therapy in tongue carcinoma patient with malnourished and cachexia undergoing chemoradiotherapy. Case: A 52-year-old man with squamous cell carcinoma of the tongue presented with clinically severe malnutrition and cachexia. Imaging revealed a solid mass involving the entire tongue and extending to the floor of the mouth, resulting in dysphagia. He undergo locoregional Intensity-Modulated Radiation Therapy (IMRT) 70/56 Gy in 35 fractions in concomitant with chemotherapy. Nutritional management involves enteral feeding with a gradual increase in energy intake from 40 kcal/kg body weight (BW) to 63 kcal/kg BW and protein from 2 to 3 g/kg BW. The patient received daily micronutrient supplementation consisting of 1 tablet of vitamin B complex three times daily, vitamin C 50 mg twice daily, zinc 20 mg twice daily, folic acid 500 mcg once daily. He also given 1 gram eicosapentaenoic acid (EPA). After one month, the patient demonstrated a weight gain of 1.8 kg (4.3%), increased handgrip strength, and functional capacity. Body composition analysis demonstrated increase in fat-free mass index (FFMI) from 15.2 to 15.8 kg/m2, skeletal muscle index (SMI) from 5.6% to 5.9%, and fat mass from 5.3% to 5.6%. Conclusion: Adequate energy and high protein intake along with micronutrients and EPA supplementation may help prevent deterioration of nutritional status, increase body weight, preserve muscle mass, and improve functional capacity in cancer patient undergoing chemoradiotherapy.

Downloads

Download data is not yet available.

Author Biographies

Diana Sunardi, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Indonesia Division of Clinical Nutrition Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Nurul Ratna Mutu Manikam, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Department of Nutrition, Faculty of Medicine, Universitas Indonesia, Indonesia Division of Clinical Nutrition Cipto Mangunkusumo Hospital, Jakarta, Indonesia

References

Bao X, Liu F, Lin J, Chen L, Chen F, Wang J. Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study. BMC Cancer. 2020;1–8.

Findlay M, White K, Brown C, Bauer JD. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes. J Cachexia Sarcopenia Muscle. 2021;(6):2187–9.

Talwar B, Donnelly R, Skelly R, Donaldson M. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(Suppl.S2):1-9.

Liu W, Gao L, Huang X, Luo J, Zhang S, Wang K, et al. Pretreatment nutritional risk as a prognostic factor in head and neck cancer patients receiving radiotherapy or chemoradiotherapy. Asia Pac J Clin Nutr. 2019;(2):1–7.

Muthanandam S, Muthu J. Understanding cachexia in head and neck cancer. Asia Pac J Oncol Nurs. 2021;8(5):527-38.

Setyawan A, Djakaria HM. Efek dasar radiasi pada jaringan. Radioterapi & onkologi Indonesia. 2014;25–33.

Huang KC, Chiang YF, Ali M, Hsia SM. Cisplatin-Induced Muscle Wasting and Atrophy: Molecular Mechanism and Potential Therapeutic Interventions. J Cachexia Sarcopenia Muscle. 2025;16(3):1-18.

van de Worp WRPH, Schols AMWJ, Theys J, Helvoort AV, Langen RCJ. Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives from Experimental Models. Front Nutr. 2020;(7):1–16.

James S, Oppermann A, Schotz KM, Minotti MM, Rao GG, Kleckner IR, et al. Nutritional counseling during chemotherapy treatment: a systematic review of feasibility, safety, and efficacy. Curr Oncol. 2025;32(1):1–41.

Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition. 2021;40(5):2898–913.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. 2017:11-48.

Valle SD, Colatruglio S, La Vela V, Tagliabue E, Mariani L, Gavazzi C. Nutritional intervention in head and neck cancer patients during chemo-radiotherapy. Nutrition. 2018;(51):95–7.

Putri GN, Manikam NRM, Andayani DE, Trismiyanti, Halim L. Successful nutritional therapy at home for a patient with invasive breast carcinoma: A case report. Asia Pac J Oncol Nurs. 2023;(10):1–5.

Tobberup R, Rasmussen HH, Holst M, Jensen NA, Falkmer UG, Bogsted M, et al. Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer. Clin Nutr ESPEN. 2019;1–7.

Ajomiwe N, Boland M, Phongthai S, Bagiyal M, Singh J, Kaur L. Protein nutrition: understanding structure, digestibility, and bioavailability for optimal health. Foods. 2024;13(11):1–15.

Sarathy SP, Ravikumar H, Nanjan P, Alagesan N, Chua BL. Plant-based protein: a multi-nutritional sustainable alternative to animal foods and their structure, functions, and relationship: a review. Int J Biol Macromol. 321(3).

Van Zanten ARH, Deutz NE, Prso AML, Prado CM, Schooneman MG, Soeters MR, et al. Shaping the future of muscle health: a clinical nutrition perspective and research agenda. Clinical Nutrition. 2026:1-18.

Munhoz J, Mazurak V, Field CJ. Perspective: implications of docosahexaenoic acid and eicosapentaenoic acid supplementation on the immune system during cancer chemotherapy: perspectives from current clinical evidence. Advance in Nutrition. 2025;(16):1–11.

Arribas L, Hurtos L, Esteve A, Peiro I, Tampan ARG, Choulli M, et al. Nutritional impact of eicosapentaenoic acid supplementation (EPA) in patients with locally advanced head and neck cancer: a double-blind placebo-controlled randomized trial. Nutr J. 2025;24(140):1-13.

Hosseini F, Hemmati A, Takabi FS, Naeini F, Bidar SS. A dose–response meta-analysis of randomized clinical trials investigating the effects of omega-3 supplementation on body weight in patients with cancer cachexia. Clin Nutr ESPEN. 2024;378–86.

Schueren MAEDVD, Laviano A, Blanchard H, Jourdan M, Arends J, Baracos VE. Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials. Ann Oncol. 2018;29(5):1141–53.

Menteri Kesehatan Republik Indonesia. Peraturan menteri kesehatan Republik Indonesia nomor 28 tahun 2019 tentang angka kecukupan gizi yang dianjurkan untuk masyarakat indonesia. 2019:1-34.

Frost Z, Bakhit S, Amaefuna CN, Powers RV, Ramana KV. Recent advances on the role of B vitamins in cancer prevention and progression. Int J Mol Sci. 2025;26(5):1–34.

Yousafzai NA, Jin H, Ullah M, Wang X. Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer. Am J Cancer. 2021;11(11):5233–48.

Islam MM, Sultana N, Liu C, Mao A, Katsube T, Wang B. Impact of dietary ingredients on radioprotection and radiosensitization: a comprehensive review. Annals of Medicine. 2024;56:1-23.

Woldeselassie M, Tamene A. Therapeutic controversies over use of antioxidant supplements during cancer treatment: a scoping review. Front Nutr. 2024;(11):1–15.

Submitted

2025-12-11
Accepted
2026-03-31
Published
2026-08-31